Early postnatal oestradiol exposure causes insulin resistance and signs of inflammation in circulation and skeletal muscle

Journal of Endocrinology

Volumn 201, Issue 1, 2009, Pages 49-58

  Alexanderson, Camilla ^a   Eriksson, Elias ^a   Stener Victorin, Elisabet ^a   Lönn, Malin ^b   Holmáng, Agneta ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CARNITINE PALMITOYLTRANSFERASE I; COMPLEMENT COMPONENT C3; ESTRADIOL; GLUCOSE; GLUCOSE TRANSPORTER 4; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INSULIN; LEPTIN; LIPOPROTEIN LIPASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RETINOL BINDING PROTEIN 4; TRANSFORMING GROWTH FACTOR BETA1; UNCOUPLING PROTEIN 2; UNCOUPLING PROTEIN 3;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CIRCULATION; CONTROLLED STUDY; DOWN REGULATION; ENVIRONMENTAL EXPOSURE; FEMALE; GENE EXPRESSION; GLUCOSE METABOLISM; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; NONHUMAN; NUCLEOTIDE SEQUENCE; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; SKELETAL MUSCLE; TISSUE DISTRIBUTION; VAGINA SMEAR; AGE; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; GENE EXPRESSION REGULATION; IMMUNOLOGY; METABOLISM; NEWBORN; PATHOLOGY; WISTAR RAT;

ADIPOSE TISSUE; AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; BLOOD CIRCULATION; BODY WEIGHT; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION; GLUCOSE; INFLAMMATION; INSULIN RESISTANCE; LIPID METABOLISM; MUSCLE, SKELETAL; RATS; RATS, WISTAR; VAGINAL SMEARS;

EID: 67651009611     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-08-0534     Document Type: Article

References (94)

1. Alexanderson C, Eriksson E, Stener-Victorin E, Lystig T, Gabrielsson B, Lonn M & Holmang A 2007 Postnatal testosterone exposure results in insulin resistance, enlarged mesenteric adipocytes, and an atherogenic lipid profile in adult female rats: comparisons with estradiol and dihydrotestosterone. Endocrinology 148 5369-5376.
2. Andersen CL, Jensen JL & Orntoft TF 2004 Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Research 64 5245-5250.
3. Applied Biosystems 2006 Application Note: Amplification Efficiency of TaqMan Gene Expression Assays., Foster City, CA: Applied Biosystems.
4. Arai Y 1964 Persistent-estrous and -diestrous conditions induced by early postnatal administration of estrogen in female rats. Endocrinologia Japonica 11 204-208.
5. Baggiolini M 1998 Chemokines and leukocyte traffic. Nature 392 565-568.
6. Barker DJ 1990 The fetal and infant origins of adult disease. BMJ 301 1111.
7. Barker DJ, Hales CN, Fall CH, Osmond C, Phipps K & Clark PM 1993 Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 36 62-67.
8. Barnum SR & Volanakis JE 1989 Structure and function of C3. Year in Immunology 6 208-228.
9. Barraclough C 1979 Sex differentiation of cyclic gonadotropin secretion. In Advances in the Biosciences, pp 433-450. Eds A Kaye & M Kaye. Oxford: Pergamon Press.
10. Bezaire V, Seifert EL & Harper M-E 2007 Uncoupling protein-3: clues in an ongoing mitochondrial mystery. FASEB Journal 21 312-324.
11. Bjornheden T, Jakubowicz B, Levin M, Oden B, Eden S, Sjostrom L & Lonn M 2004 Computerized determination of adipocyte size. Obesity Research 12 95-105.
12. Boullu-Ciocca S, Tassistro V, Dutour A & Grino M 2008 Postnatal programming of glucocorticoid metabolism in rats modulates high-fat diet-induced regulation of visceral adipose tissue glucocorticoid exposure and sensitivity and adiponectin and proinflammatory adipokines gene expression in adulthood. Diabetes 57 669-677.
13. Boyd JH, Divangahi M, Yahiaoui L, Gvozdic D, Qureshi S & Petrof BJ 2006 Toll-like receptors differentially regulate CC and CXC chemokines in skeletal muscle via NF-κB and calcineurin. Infection and Immunity 74 6829-6838.
14. Carey A, Petersen E, Bruce C, Southgate R, Pilegaard H, Hawley J, Pedersen B & Febbraio M 2006 Discordant gene expression in skeletal muscle and adipose tissue of patients with type 2 diabetes: effect of interleukin-6 infusion. Diabetologia 49 1000-1007.
15. Cianflone K & Maslowska M 1995 Differentiation-induced production of ASP in human adipocytes. European Journal of Clinical Investigation 25 817-825.
16. Cianflone K, Maslowska M & Sniderman AD 1999 Acylation stimulating protein (ASP), an adipocyte autocrine: new directions. Seminars in Cell and Developmental Biology 10 31-41.
17. Cianflone K, Xia Z & Chen LY 2003 Critical review of acylation-stimulating protein physiology in humans and rodents. Biochimica et Biophysica Acta/Biomembranes 1609 127-143.
18. Confalonieri P, Bernasconi P, Megna P, Galbiati S, Cornelio F & Mantegazza R 2000 Increased expression of beta-chemokines in muscle of patients with inflammatory myopathies. Journal of Neuropathology and Experimental Neurology 59 164-169.
19. Cooke PS & Naaz A 2004 Role of estrogens in adipocyte development and function. Experimental Biology and Medicine 229 1127-1135.
20. DeFronzo RA 1988 Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 37 667-687.
21. DeFronzo R 1992 Pathogenesis of type 2 (non-insulin dependent) diabetes mellitus: a balanced overview. Diabetologia 35 389-397.
22. DeHaan KC, Berger LL, Bechtel PJ, Kesler DJ, McKeith FK & Thomas DL 1990 Effect of prenatal testosterone treatment on nitrogen utilization and endocrine status of ewe lambs. Journal of Animal Science 68 4100-4108.
23. Dressel U, Allen TL, Pippal JB, Rohde PR, Lau P & Muscat GEO 2003 The peroxisome proliferator-activated receptor b/d agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells. Molecular Endocrinology 17 2477-2493.
24. Eisner J, Dumesic D, Kemnitz J & Abbott D 2000 Timing of prenatal androgen excess determines differential impairment in insulin secretion and action in adult female rhesus monkeys. Journal of Clinical Endocrinology and Metabolism 85 1206-1210.
25. Eisner JR, Dumesic DA, Kemnitz JW, Colman RJ & Abbott DH 2003 Increased adiposity in female rhesus monkeys exposed to androgen excess during early gestation. Obesity Research 11 279-286.
26. Fernández-Real JM & Pickup JC 2008 Innate immunity, insulin resistance and type 2 diabetes. Trends in Endocrinology and Metabolism 19 10-16.
27. Germinario R, Sniderman AD, Manuel S, Lefebvre SP, Baldo A & Cianflone K 1993 Coordinate regulation of triacylglycerol synthesis and glucose transport by acylation-stimulating protein. Metabolism 42 574-580.
28. Gill JW & Hosking BJ 1995 Acute prenatal androgen treatment increases birth weights and growth rates in lambs. Journal of Animal Science 73 2600-2608.
29. Graham TL, Mookherjee C, Suckling KE, Palmer CN & Patel L 2005 The PPAR[delta] agonist GW0742X reduces atherosclerosis in LDLR -/- mice. Atherosclerosis 181 29-37.
30. Gregoire F, Smas C & Sul H 1998 Understanding adipocyte differentiation. Physiological Reviews 78 783-809.
31. Grimble RF 2002 Inflammatory status and insulin resistance. Current Opinion in Clinical Nutrition and Metabolic Care 5 551-559.
32. Hansen LR, Drackley JK, Berger LL & Grum DE 1995 Prenatal androgenization of lambs: I. Alterations of growth, carcass characteristics, and metabolites in blood. Journal of Animal Science 73 1694-1700.
33. Van Harmelen V, Reynisdottir S, Eriksson P, Thorne A, Hoffstedt J, Lonnqvist F & Arner P 1998 Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes 47 913-917.
34. Holmang A, Svedberg J, Jennische E & Bjorntorp P 1990 Effects of testosterone on muscle insulin sensitivity and morphology in female rats. American Journal of Physiology. Endocrinology and Metabolism 259 E555-E560.
35. Janke J, Engeli S, Boschmann M, Adams F, Bohnke J, Luft FC, Sharma AM & Jordan J 2006 Retinol-binding protein 4 in human obesity. Diabetes 55 2805-2810.
36. Jernas M, Palming J, Sjoholm K, Jennische E, Svensson P-A, Gabrielsson BG, Levin M, Sjogren A, Rudemo M, Lystig TC et al. 2006 Separation of human adipocytes by size: hypertrophic fat cells display distinct gene expression. FASEB Journal 20 1540-1542.
37. Jones TE, Baar K, Ojuka E, Chen M & Holloszy JO 2003 Exercise induces an increase in muscle UCP3 as a component of the increase in mitochondrial biogenesis. American Journal of Physiology. Endocrinology and Metabolism 284 E96-E101.
38. Kang L, Sebastian BM, Pritchard MT, Pratt BT, Previs SF & Nagy LE 2007 Chronic ethanol-induced insulin resistance is associated with macrophage infiltration into adipose tissue and altered expression of adipocytokines. Alcoholism: Clinical and Experimental Research 31 1581-1588.
39. Kent JW Jr, Comuzzie AG, Mahaney MC, Almasy L, Rainwater DL, VandeBerg JL, MacCluer JW & Blangero J 2004 Intercellular adhesion molecule-1 concentration is genetically correlated with insulin resistance, obesity, and HDL concentration in mexican americans. Diabetes 53 2691-2695.
40. Kerner J & Hoppel C 2000 Fatty acid import into mitochondria. Biochimica et Biophysica Acta/Molecular and Cell Biology of Lipids 1486 1-17.
41. King AJ, Bari Olivier N, Mohankumar PS, Lee JS, Padmanabhan V & Fink GD 2007 Hypertension caused by prenatal testosterone excess in female sheep. American Journal of Physiology. Endocrinology and Metabolism 292 E1837-E1841.
42. Kollias HD & McDermott JC 2008 Transforming growth factor-β and myostatin signaling in skeletal muscle. Journal of Applied Physiology 104 579-587.
43. Krook A, Digby J, O'Rahilly S, Zierath J & Wallberg-Henriksson H 1998 Uncoupling protein 3 is reduced in skeletal muscle of NIDDM patients. Diabetes 47 1528-1531.
44. Legoedec J, Gasque P, Jeanne JF & Fontaine M 1995 Expression of the complement alternative pathway by human myoblasts in vitro: biosynthesis of C3, factor B, factor H and factor I. European Journal of Immunology 25 3460-3466.
45. Letterio JJ & Roberts AB 1998 Regulation of immune responses by TGFbeta. Annual Review of Immunology 16 137-161.
46. Li AC, Binder CJ, Gutierrez A, Brown KK, Plotkin CR, Pattison JW, Valledor AF, Davis RA, Willson TM, Witztum JL et al. 2004 Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma. Journal of Clinical Investigation 114 1564-1576.
47. Libby P 2002 Inflammation in atherosclerosis. Nature 420 868-874.
48. Livak KJ & Schmittgen TD 2001 Analysis of relative gene expression data using real-time quantitative PCR and the 2-[Delta][Delta]CT method. Methods 25 402-408.
49. Lombardo SA, Leanza G, Meli C, Lombardo ME, Mazzone L, Vincenti I & CioniM2005 Maternal exposure to the antiepileptic drug vigabatrin affects postnatal development in the rat. Neurological Sciences 26 89-94.
50. de Luca C & Olefsky JM 2008 Inflammation and insulin resistance. FEBS Letters 582 97-105.
51. Lucas A 1991 Programming by early nutrition in man. Ciba Foundation Symposia 156 38-50 (discussion 50-35).
52. Manco M, Calvani M & Mingrone G 2004 Effects of dietary fatty acids on insulin sensitivity and secretion. Diabetes, Obesity and Metabolism 6 402-413.
53. Marcondes FK, Bianchi FJ & Tanni AP 2002 Determination of the estrous cycle phases of rats: some helpful considerations. Brazilian Journal of Biology 62 609-614.
54. Muhlhausler BS, Duffield JA & McMillen IC 2007 Increased maternal nutrition increases leptin expression in perirenal and subcutaneous adipose tissue in the postnatal lamb. PG - 6157-63. Endocrinology 148 6157-6163.
55. Muoio DM, MacLean PS, Lang DB, Li S,Houmard JA,Way JM, Winegar DA, Corton JC, Dohm GL & Kraus WE 2002 Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR) alpha knock-out mice. Evidence for compensatory regulation by PPARdelta. Journal of Biological Chemistry 277 26089-26097.
56. Nagasawa T, Inada Y, Nakano S, Tamura T, Takahashi T, Maruyama K, Yamazaki Y, Kuroda J & Shibata N 2006 Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPAR[delta] agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet. European Journal of Pharmacology 536 182-191.
57. Newbold RR, Jefferson WN, Padilla-Banks E & Haseman J 2004 Developmental exposure to diethylstilbestrol (DES) alters uterine response to estrogens in prepubescent mice: low versus high dose effects. Reproductive Toxicology 18 399-406.
58. Nomura S, Shouzu A, Omoto S, Nishikawa M & Fukuhara S 2000 Significance of chemokines and activated platelets in patients with diabetes. Clinical and Experimental Immunology 121 437-443.
59. Ozanne SE, Wang CL, Coleman N & Smith GD 1996 Altered muscle insulin sensitivity in the male offspring of protein-malnourished rats. American Journal of Physiology. Endocrinology and Metabolism 271 E1128-E1134.
60. Pecqueur C, Couplan E, Bouillaud F & Ricquier D 2001 Genetic and physiological analysis of the role of uncoupling proteins in human energy homeostasis. Journal of Molecular Medicine 79 48-56.
61. Pedersen BK, Akerstrom TCA, Nielsen AR & Fischer CP 2007 Role of myokines in exercise and metabolism. Journal of Applied Physiology 103 1093-1098.
62. Perello M, Castrogiovanni D, Giovambattista A, Gaillard RC & Spinedi EL 2003 Neonatal hypothalamic androgenization in the female rat induces changes in peripheral insulin sensitivity and adiposity function at adulthood. Neuroendocrinology Letters 24 241-248.
63. Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan C, Rothman DL, DiPietro L, Cline GW & Shulman GI 2003 Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 300 1140-1142.
64. Petersen KF, Dufour S, Befroy D, Garcia R & Shulman GI 2004 Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. New England Journal of Medicine 350 664-671.
65. Pfeiffer A, Middelberg-Bisping K, Drewes C & Schatz H 1996 Elevated plasma levels of transforming growth factor-beta 1 in NIDDM. Diabetes Care 19 1113-1117.
66. Pinilla L, Barreiro M, Gonzalez L, Tena-Sempere M & Aguilar E 2002 Comparative effects of testosterone propionate, oestradiol benzoate, ICI 182,780, tamoxifen and raloxifene on hypothalamic differentiation in the female rat. Journal of Endocrinology 172 441-448.
67. Recabarren SE, Padmanabhan V, Codner E, Lobos A, Duran C, Vidal M, Foster DL & Sir-Petermann T 2005 Postnatal developmental consequences of altered insulin sensitivity in female sheep treated prenatally with testosterone. American Journal of Physiology. Endocrinology and Metabolism 289 E801-E806.
68. Reilly SM & Lee C-H 2008 PPAR[delta] as a therapeutic target in metabolic disease. FEBS Letters 582 26-31.
69. Rollins BJ 1997 Chemokines. Blood 90 909-928.
70. Romano M, Guagnano MT, Pacini G, Vigneri S, Falco A, Marinopiccoli M, Manigrasso MR, Basili S & Davi G 2003 Association of inflammation markers with impaired insulin sensitivity and coagulative activation in obese healthy women. Journal of Clinical Endocrinology and Metabolism 88 5321-5326.
71. Saghizadeh M, Ong JM, Garvey WT, Henry RR & Kern PA 1996 The expression of TNF alpha by human muscle. Relationship to insulin resistance. Journal of Clinical Investigation 97 1111-1116.
72. Schrauwen P, Hesselink MK, Blaak EE, Borghouts LB, Schaart G, Saris WH & Keizer HA 2001 Uncoupling protein 3 content is decreased in skeletal muscle of patients with type 2 diabetes. Diabetes 50 2870-2873.
73. Schuler M, Ali F, Chambon C, Duteil D, Bornert J-M, Tardivel A, Desvergne B, Wahli W, Chambon P & Metzger D 2006 PGC1[alpha] expression is controlled in skeletal muscles by PPAR[beta], whose ablation results in fiber-type switching, obesity, and type 2 diabetes. Cell Metabolism 4 407-414.
74. Sell H, Dietze-Schroeder D, Kaiser U & Eckel J 2006 Monocyte chemotactic protein-1 is a potential player in the negative cross-talk between adipose tissue and skeletal muscle. Endocrinology 147 2458-2467.
75. Serrero G & Mills D 1991 Decrease in transforming growth factor beta 1 binding during differentiation of rat adipocyte precursors in primary culture. Cell Growth and Differentiation 2 173-178.
76. Shankar K, Harrell A, Liu X, Gilchrist JM, Ronis MJJ & Badger TM 2008 Maternal obesity at conception programs obesity in the offspring. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 294 R528-R538.
77. Shen W, Hao J, Tian C, Ren J, Yang L, Li X, Luo C, Cotma CW & Liu J 2008 A combination of nutriments improves mitochondrial biogenesis and function in skeletal muscle of type 2 diabetic Goto-Kakizaki rats. PLoS ONE 4 2328.
78. Smith U, Sjostrom L & Bjorntorp P 1972 Comparison of two methods for determining human adipose cell size. Journal of Lipid Research 13 822-824.
79. Sopasakis VR, Sandqvist M, Gustafson B, Hammarstedt A, Schmelz M, Yang X, Jansson PA & Smith U 2004 High local concentrations and effects on differentiation implicate interleukin-6 as a paracrine regulator. Obesity Research 12 454-460.
80. Sotomayor-Zarate R, Dorfman M, Paredes A & Lara HE 2008 Neonatal exposure to estradiol valerate programs ovarian sympathetic innervation and follicular development in the adult rat. Biology of Reproduction 78 673-680.
81. van de Stolpe A & van der Saag PT 1996 Intercellular adhesion molecule-1. Journal of Molecular Medicine 74 13-33.
82. Szmitko PE, Wang C-H, Weisel RD, de Almeida JR, Anderson TJ & Verma S 2003 New markers of inflammation and endothelial cell activation: part I. Circulation 108 1917-1923.
83. Tao Y, Cianflone K, Sniderman AD, Colby-Germinario SP & Germinario RJ 1997 Acylation-stimulating protein (ASP) regulates glucose transport in the rat L6 muscle cell line. Biochimica et Biophysica Acta/Lipids and Lipid Metabolism 1344 221-229.
84. Vaag A, Jensen CB, Poulsen P, Bruns C, Pilgaard K, Grunnet L, Vielwerth S & Alibegovic A 2006 Metabolic aspects of insulin resistance in individuals born small for gestational age. Hormone Research 65 137-143.
85. Vickers MH 2007 Developmental programming and adult obesity: the role of leptin. Current Opinion in Endocrinology, Diabetes and Obesity 14 17-22.
86. Wang Y-X, Lee C-H, Tiep S, Yu RT, Ham J, Kang H & Evans RM 2003 Peroxisome-proliferator-activated receptor [delta] activates fat metabolism to prevent obesity. Cell 113 159-170.
87. Wei Y, Chen K, Whaley-Connell AT, Stump CS, Ibdah JA & Sowers JR 2008 Skeletal muscle insulin resistance: role of inflammatory cytokines and reactive oxygen species. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 294 R673-R680.
88. Weyer C, Foley J, Bogardus C, Tataranni PA & Pratley RE 2000 Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia 43 1498-1506.
89. Winkler G, Kiss S, Keszthelyi L, Sapi Z, Ory I, Salamon F, Kovacs M, Vargha P, Szekeres O, Speer G et al. 2003 Expression of tumor necrosis factor (TNF)-alpha protein in the subcutaneous and visceral adipose tissue in correlation with adipocyte cell volume, serum TNF-alpha, soluble serum TNF-receptor-2 concentrations and C-peptide level. European Journal of Endocrinology 149 129-135.
90. Xia Z & Cianflone K 2003 Acylation-stimulating protein precursor proteins in adipose tissue in human obesity. Metabolism 52 1360-1366.
91. Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, Kotani K, Quadro L & Kahn BB 2005 Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 436 356-362.
92. Yao-Borengasser A, Varma V, Bodles AM, Rasouli N, Phanavanh B, Lee M-J, Starks T, Kern LM, Spencer HJ III, Rashidi AA et al. 2007 Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone. Journal of Clinical Endocrinology and Metabolism 92 2590-2597.
93. Yasruel Z, Cianflone K, Sniderman AD, Rosenbloom M, Walsh M & Rodriguez MA 1991 Effect of acylation stimulating protein on the triacylglycerol synthetic pathway of human adipose tissue. Lipids 26 495-499.
94. Zhang YG, Diaz PA, Heo M & Leibel R 2002 Determinants of leptin gene expression in fat depots of lean mice. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 282 R226-R234.